Technical Analysis for GCTK - GlucoTrack, Inc.

Grade Last Price % Change Price Change
F 0.25 -12.26% -0.04
GCTK closed up 6.19 percent on Monday, November 18, 2024, on 5.49 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Volume Surge Other -12.26%
Calm After Storm Range Contraction -12.26%
Narrow Range Bar Range Contraction -12.26%
Lower Bollinger Band Walk Weakness -12.26%
New 52 Week Low Weakness -12.26%
Outside Day Range Expansion -12.26%
Wide Bands Range Expansion -12.26%
Oversold Stochastic Weakness -12.26%
New 52 Week Closing Low Bearish -6.82%
Volume Surge Other -6.82%

   Recent Intraday Alerts

Alert Time
Possible NR7 17 minutes ago
10x Volume Pace about 4 hours ago
2x Volume Pace about 4 hours ago
1.5x Volume Pace about 4 hours ago
3x Volume Pace about 4 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Clinical Medicine Pain Diabetes Glucose Blood Test Medical Monitoring Blood Glucose Monitoring Diabetes Management Blood Sugar Level Endocrine Diseases

Is GCTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.95
52 Week Low 0.2524
Average Volume 327,594
200-Day Moving Average 2.00
50-Day Moving Average 2.01
20-Day Moving Average 1.38
10-Day Moving Average 0.95
Average True Range 0.29
RSI (14) 21.88
ADX 32.02
+DI 20.04
-DI 39.46
Chandelier Exit (Long, 3 ATRs) 1.58
Chandelier Exit (Short, 3 ATRs) 1.11
Upper Bollinger Bands 2.58
Lower Bollinger Band 0.18
Percent B (%b) 0.05
BandWidth 174.40
MACD Line -0.44
MACD Signal Line -0.32
MACD Histogram -0.1223
Fundamentals Value
Market Cap 6.02 Million
Num Shares 20.9 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -0.78
Price-to-Sales 0.00
Price-to-Book 0.85
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.38
Resistance 3 (R3) 0.38 0.34 0.36
Resistance 2 (R2) 0.34 0.32 0.35 0.36
Resistance 1 (R1) 0.32 0.31 0.33 0.32 0.35
Pivot Point 0.28 0.28 0.29 0.29 0.28
Support 1 (S1) 0.26 0.26 0.27 0.26 0.22
Support 2 (S2) 0.22 0.25 0.22 0.22
Support 3 (S3) 0.20 0.22 0.21
Support 4 (S4) 0.20